Author Information
Amanda-lelia Rădulescu is affiliated with the Clinical Hospital of Infectious Diseases and the University of Medicine and Pharmacy "Iuliu Hațieganu" in Cluj-Napoca, Romania. Her work primarily focuses on infectious diseases, contributing significantly to the understanding and management of various infections, including COVID-19, hepatitis, and HIV, within Romania.Research Contributions
Amanda-lelia Rădulescu has made notable contributions to the field of infectious diseases through her research and publications. Her studies cover a wide range of topics, including the treatment of COVID-19 pneumonia with Tocilizumab, seroprevalence of Borrelia burgdorferi, kinetics of antibodies and viral RNA in SARS-CoV-2, and comparative analysis of hepatitis E and A. Additionally, she has explored the risks posed by accidental exposure to biological products to medical staff and patients, and the variability in antibody titers among vaccinated cohorts. Her work also addresses the attitudes and practices regarding HIV screening and testing in Romania, highlighting her diverse research interests within the infectious diseases domain.Aliases
Amanda-lelia Rădulescu is known by several aliases, including Amanda Radulescu, Amanda Rădulescu, A. Radulescu, and Amanda Lelia Rădulescu. These variations may appear in different publications or databases.Publication and Citation Metrics
| Metric |
Value |
| Total Papers |
43 |
| Citation Count |
88 |
| h-index |
6 |
